The regrouping of Luminal B ( <scp>HER2</scp> negative), a better discriminator of outcome and recurrence score-Reference-Cited by-同舟云学术

The regrouping of Luminal B ( HER2 negative), a better discriminator of outcome and recurrence score

Published:2022-07-31 Issue:3 Volume:12 Page:2493-2504
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Yang Zheng‐Jun¹²³,Liu Yu‐Xiao¹²³,Huang Yue¹²³,Chen Zu‐Jin¹²³,Zhang Hao‐Zhi²⁴,Yu Yue¹²³^ORCID,Wang Xin¹²³,Cao Xu‐Chen¹²³^ORCID

Affiliation:

1. The First Department of Breast Cancer Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer Tianjin China

2. Key Laboratory of Cancer Prevention and Therapy Tianjin China

3. Key Laboratory of Breast Cancer Prevention and Therapy Tianjin Medical University, Ministry of Education Tianjin China

4. Department of Thyroid and Neck Cancer Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Tianjin's Clinical Research Center for Cancer Tianjin China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.5089

Reference37 articles.

1. Cancer Statistics, 2021

2. Cancer burden of major cancers in China: A need for sustainable actions

3. The prognostic value of node status in different breast cancer subtypes